Skip navigation
  • Sciety Labs 🧪 (Experimental)
  • Search
Sciety application utilities

Microbiology

  • Subscribe to feed (RSS)

Showing page 132 of 255 pages of list content

  • Metformin Suppresses SARS-CoV-2 in Cell Culture

    This article's authors
    1. Haripriya Parthasarathy
    2. Dixit Tandel
    3. Abdul Hamid Siddiqui
    4. Krishnan H. Harshan
    This article has 1 evaluations Latest evaluation on Nov 30, 2021 Published on Jul 29, 2022
  • LRRC15 is an inhibitory receptor blocking SARS-CoV-2 spike-mediated entry in trans

    This article's authors
    1. Jaewon Song
    2. Ryan D. Chow
    3. Mario Pena-Hernandez
    4. Li Zhang
    5. Skylar A. Loeb
    6. Eui-Young So
    7. Olin D. Liang
    8. Craig B. Wilen
    9. Sanghyun Lee
    This article has 1 evaluations Latest evaluation on Nov 30, 2021 Published on Nov 24, 2021
  • SARS-CoV-2 Delta Spike Protein Enhances the Viral Fusogenicity and Inflammatory Cytokine Production

    This article's authors
    1. Zhujun Ao
    2. Maggie Jing Ouyang
    3. Titus Abiola Olukitibi
    4. Xiaojian Yao
    This article has 1 evaluations Latest evaluation on Nov 30, 2021 Published on Nov 24, 2021
  • Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities

    This article's authors
    1. Yaozong Chen
    2. Lulu Sun
    3. Irfan Ullah
    4. Guillaume Beaudoin-Bussières
    5. Sai Priya Anand
    6. Andrew P. Hederman
    7. William D. Tolbert
    8. Rebekah Sherburn
    9. Dung N. Nguyen
    10. Lorie Marchitto
    11. Shilei Ding
    12. Di Wu
    13. Yuhong Luo
    14. Suneetha Gottumukkala
    15. Sean Moran
    16. Priti Kumar
    17. Grzegorz Piszczek
    18. Walther Mothes
    19. Margaret E. Ackerman
    20. Andrés Finzi
    21. Pradeep D. Uchil
    22. Frank J. Gonzalez
    23. Marzena Pazgier
    This article has 1 evaluations Latest evaluation on Nov 30, 2021 Published on Nov 24, 2021
  • RNase III-mediated processing of a trans -acting bacterial sRNA and its cis -encoded antagonist

    This article's authors
    1. Sarah L. Svensson
    2. Cynthia M. Sharma
    This article has 9 evaluations Latest evaluation on Dec 6, 2021 Published on Nov 15, 2021
  • Antiviral activity of Molnupiravir precursor NHC against SARS-CoV-2 Variants of Concern (VOCs) and implications for the therapeutic window and resistance

    This article's authors
    1. Tessa Prince
    2. I’ah Donovan-Banfield
    3. Hannah Goldswain
    4. Rebekah Penrice-Randal
    5. Catherine Hartley
    6. Saye Khoo
    7. Tom Fletcher
    8. Julian A. Hiscox
    This article has 1 evaluations Latest evaluation on Nov 30, 2021 Published on Feb 2, 2023
  • SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade

    This article's authors
    1. Firdaus Samsudin
    2. Palur Raghuvamsi
    3. Ganna Petruk
    4. Manoj Puthia
    5. Jitka Petrlova
    6. Paul MacAry
    7. Ganesh S. Anand
    8. Artur Schmidtchen
    9. Peter J. Bond
    This article has 4 evaluations Latest evaluation on Feb 14, 2022 Published on Nov 6, 2021
  • Glycan-masking spike antigen in NTD and RBD elicits broadly neutralizing antibodies against SARS-CoV-2 variants

    This article's authors
    1. Wei-Shuo Lin
    2. I-Chen Chen
    3. Hui-Chen Chen
    4. Yi-Chien Lee
    5. Suh-Chin Wu
    This article has 1 evaluations Latest evaluation on Nov 19, 2021 Published on Nov 2, 2021
  • Inactivation of SARS Coronavirus 2 and COVID-19 patient samples for contemporary immunology and metabolomics studies

    This article's authors
    1. Devon J. Eddins
    2. Leda Bassit
    3. Joshua D. Chandler
    4. Natalie S. Haddad
    5. Katie L. Musall
    6. Junkai Yang
    7. Astrid Kosters
    8. Brian S. Dobosh
    9. Mindy R. Hernández
    10. Richard P. Ramonell
    11. Rabindra M. Tirouvanziam
    12. F. Eun-Hyung Lee
    13. Keivan Zandi
    14. Raymond F. Schinazi
    15. Eliver E.B. Ghosn
    This article has 1 evaluations Latest evaluation on Nov 19, 2021 Published on Oct 24, 2021
  • Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice

    This article's authors
    1. Gema M. Olivarria
    2. Yuting Cheng
    3. Susana Furman
    4. Collin Pachow
    5. Lindsay A. Hohsfield
    6. Charlene Smith-Geater
    7. Ricardo Miramontes
    8. Jie Wu
    9. Mara S. Burns
    10. Kate I. Tsourmas
    11. Jennifer Stocksdale
    12. Cynthia Manlapaz
    13. William H. Yong
    14. John Teijaro
    15. Robert Edwards
    16. Kim N. Green
    17. Leslie M. Thompson
    18. Thomas E. Lane
    This article has 1 evaluations Latest evaluation on Nov 20, 2021 Published on Nov 17, 2021
Previous Next
Stay updated. Get involved.
Subscribe to Mailing List
  • Blog
  • About Sciety
  • Contact
  • Follow us on Twitter
  • Follow us on Facebook
© 2022 eLife Sciences Publications Ltd. Legal information